{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:58Z","timestamp":1793214658051,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":93,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008130","name":"Pusan National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.humpath.2025.105862","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:00:03Z","timestamp":1750849203000},"page":"105862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Diagnostic accuracy of TRIM63 RNA-ISH in MiTF-rearranged renal cell carcinomas: Results from a 331-tumor validation cohort"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2995-6060","authenticated-orcid":false,"given":"Hyun Jung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farinaz","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0819-9638","authenticated-orcid":false,"given":"Maria S.","family":"Tretiakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.105862_bib1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/PAS.0b013e3181e8ce5b","article-title":"Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib2","first-page":"125","article-title":"MiT family translocation renal cell carcinomas: a 15th anniversary update","volume":"35","author":"Gandhi","year":"2020","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.humpath.2025.105862_bib3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay","volume":"27","author":"Argani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/PAS.0b013e31827e17cb","article-title":"TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone","volume":"37","author":"Rao","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib5","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/PAS.0b013e31828a69ae","article-title":"Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service","volume":"37","author":"Green","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrurol.2014.162","article-title":"Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers","volume":"11","author":"Kauffman","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.humpath.2025.105862_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and MiTfamily translocation-driven renal neoplasms","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/his.13700","article-title":"TFE3 translocation and protein expression in renal cell carcinoma are correlated with poor prognosis","volume":"73","author":"Lee","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105862_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/PAP.0000000000000332","article-title":"Chameleon TFE3-translocation RCC and how gene partners can change morphology: accurate diagnosis using contemporary modalities","volume":"29","author":"Tretiakova","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib10","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/PAS.0000000000001541","article-title":"Morphologic and immunohistochemical characteristics of fluorescent in situ hybridization confirmed TFE3-gene fusion associated renal cell carcinoma A single institutional cohort","volume":"44","author":"Akgul","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib11","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/oncolo\/oyac158","article-title":"Efficacy of cabozantinib in metastatic MiT family translocation renal cell carcinomas","volume":"27","author":"Thouvenin","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.humpath.2025.105862_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clgc.2020.11.005","article-title":"Systemic therapies for the management of non-clear cell renal cellcarcinoma: what works, what doesn't, and what the future holds","volume":"19","author":"Zoumpourlis","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2025.105862_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s40425-018-0482-z","article-title":"Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders","volume":"6","author":"Boileve","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2025.105862_bib14","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.3390\/ijms21186663","article-title":"MuRF1\/TRIM63, master regulator of muscle mass","volume":"21","author":"Peris-Moreno","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2025.105862_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152573","article-title":"A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt\/beta-catenin signaling pathway in breast cancer","volume":"215","author":"Li","year":"2019","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2025.105862_bib16","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41379-021-00803-z","article-title":"TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma","volume":"34","author":"Wang","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib17","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/gcc.22798","article-title":"Gene fusion analysis in renal cell carcinoma by FusionPlex RNA-sequencing and correlations of molecular findings with clinicopathological features","volume":"59","author":"Tretiakova","year":"2019","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.humpath.2025.105862_bib19","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/PAS.0000000000001150","article-title":"VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney","volume":"42","author":"Wang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pathol.2019.11.006","article-title":"Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets","volume":"52","author":"Cali\u00f2","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2025.105862_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41379-018-0191-7","article-title":"NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma","volume":"32","author":"Pei","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00428-018-2509-8","article-title":"A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion","volume":"474","author":"Fukuda","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.105862_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/PAS.0000000000000837","article-title":"Xp11 translocation renal cell carcinomas (RCCs) with RBM10-TFE3 gene fusion demonstrating melanotic features and overlapping morphology with t(6;11) RCC: interest and diagnostic pitfall in detecting a paracentric inversion of TFE3","volume":"41","author":"Xia","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/modpathol.2017.99","article-title":"Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays","volume":"31","author":"Skala","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110190","article-title":"Integrative clinical and molecular characterization of translocation renal cell carcinoma","volume":"38","author":"Bakouny","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.humpath.2025.105862_bib26","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1158\/1078-0432.CCR-19-3283","article-title":"Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy-number variations as drivers of disease progression","volume":"26","author":"Marcon","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2025.105862_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.semdp.2015.02.003","article-title":"MiT family translocation renal cell carcinoma","volume":"32","author":"Argani","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2019.02.008","article-title":"Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study","volume":"87","author":"Sharain","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib30","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/jid.2010.5","article-title":"Regulation of human skin pigmentation in situ by repetitive UV exposure: molecular characterization of responses to UVA and\/or UVB","volume":"130","author":"Choi","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2025.105862_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1507\/endocrj.K09E-290","article-title":"Glucocorticoid-induced gene tripartite motif-containing 63 (TRIM63) promotes differentiation of osteoblastic cells","volume":"57","author":"Azuma","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.humpath.2025.105862_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Linehan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105862_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105797","article-title":"Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry","volume":"159","author":"Whaley","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105862_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12032-024-02305-9","article-title":"Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS)","volume":"41","author":"Taylor","year":"2024","journal-title":"Med Oncol"},{"key":"10.1016\/j.humpath.2025.105862_bib35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00428-024-03855-z","article-title":"Renal epithelioid angiomyolipomas overexpress TFE3 and the TFE3-regulated gene TRIM63 in the absence of TFE3 rearrangement","volume":"485","author":"Collins","year":"2024","journal-title":"Virchows Arch"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725001492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725001492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:11:14Z","timestamp":1759489874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725001492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":34,"alternative-id":["S0046817725001492"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105862","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic accuracy of TRIM63 RNA-ISH in MiTF-rearranged renal cell carcinomas: Results from a 331-tumor validation cohort","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105862"}}